Linde (LIN) Given Buy Rating at Kepler Capital Markets

Share on StockTwits

Kepler Capital Markets reissued their buy rating on shares of Linde (ETR:LIN) in a report published on Friday morning.

Several other research analysts have also weighed in on the company. Independent Research set a €188.24 ($218.88) price objective on Linde and gave the stock a sell rating in a research report on Tuesday, October 23rd. DZ Bank reiterated a neutral rating on shares of Linde in a research report on Monday, October 22nd. JPMorgan Chase & Co. set a €230.00 ($267.44) price objective on Linde and gave the stock a buy rating in a research report on Tuesday, October 23rd. Societe Generale set a €225.00 ($261.63) price objective on Linde and gave the stock a buy rating in a research report on Monday, October 22nd. Finally, Sanford C. Bernstein set a €169.00 ($196.51) price objective on Linde and gave the stock a sell rating in a research report on Thursday, October 18th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and ten have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of €210.78 ($245.09).

LIN stock opened at €136.20 ($158.37) on Friday. Linde has a 1 year low of €150.10 ($174.53) and a 1 year high of €199.40 ($231.86).

Linde Company Profile

Linde plc operates as an industrial gas and engineering company. The company offers oxygen, nitrogen, argon, rare gases, carbon monoxide, carbon dioxide, helium, hydrogen, electronic gases, specialty gases, acetylene, shielding gases, and noble gases, as well as develops and distributes procedures and systems for gas applications.

Featured Article: What are the Different Types of Leveraged Buyouts?

Analyst Recommendations for Linde (ETR:LIN)

Receive News & Ratings for Linde Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Linde and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.